Recombinant Human PKIa Protein，His

PKIa (Protein Kinase A type I alpha) is a crucial enzyme involved in various cellular signaling pathways that regulate key physiological processes such as metabolism, cell growth, and differentiation. The research focus on PKIa stems from its significant role in the cyclic AMP (cAMP) signaling cascade, where it serves as a major effector that transmits signals from extracellular stimuli to intracellular responses. Dysregulation of PKIa activity has been implicated in numerous diseases, including cancer, cardiovascular disorders, and neurological conditions, making it an important target for therapeutic intervention. Recent advancements in genetic engineering and recombinant protein technology have facilitated the production of PKIa in heterologous systems, enabling researchers to investigate its structural and functional properties in detail. Understanding the molecular mechanisms underlying PKIa's activity could provide insights into its role in disease and pave the way for the development of specific inhibitors or activators as potential drugs. The ongoing research aims to elucidate the intricate regulatory mechanisms governing PKIa, assess its interactions with various substrates, and explore its potential as a biomarker for disease progression. The successful characterization of PKIa as a recombinant protein not only enhances our understanding of its biological significance but also contributes to the broader field of signal transduction research, ultimately aiming to translate these findings into clinical applications.